speb/financial-data huggingface dataset:
HCA cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 647000000.00
HCA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -130000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000000.00
HCA cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -171000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -4394000000.00
HCA cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -2505000000.00
HCA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 10982000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 6585000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Current Assets: 15563000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Current Debt: 5104000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 5104000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 15939000000.00
HCA cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 388000000.00
HCA cash_flow (quarterly, 2025-06-30) — Deferred Tax: 388000000.00
HCA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 863000000.00
HCA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 863000000.00
HCA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 863000000.00
HCA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 863000000.00
HCA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 241911000.00
HCA income_statement (quarterly, 2025-06-30) — Diluted EPS: 6.83
HCA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1653000000.00
HCA income_statement (quarterly, 2025-06-30) — EBIT: 2983000000.00
HCA income_statement (quarterly, 2025-06-30) — EBITDA: 3846000000.00
HCA income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 19000000.00
HCA cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 9000000.00
HCA cash_flow (quarterly, 2025-06-30) — End Cash Position: 939000000.00
HCA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3089000000.00
HCA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 3034000000.00
HCA cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 3000000.00
HCA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: -3000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -309000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 10273000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 66544000000.00
HCA income_statement (quarterly, 2025-06-30) — Gross Profit: 7623000000.00
HCA cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 136000000.00
HCA income_statement (quarterly, 2025-06-30) — Interest Expense: 568000000.00
HCA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 568000000.00
HCA cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 535000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Inventory: 1792000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 40089000000.00
HCA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1251000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1185000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 654000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Investmentsin Subsidiariesat Cost: 531000000.00
HCA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: -220000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1881000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 39379000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 41260000000.00
HCA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: -220000000.00
HCA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -1765000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1185000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Minority Interest: 3156000000.00
HCA income_statement (quarterly, 2025-06-30) — Minority Interests: -238000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -93000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -2505000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Net Debt: 43544000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Income: 1653000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1653000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1891000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1653000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1653000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1891000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1891000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Interest Income: -568000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 13000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -217000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -1985000000.00
HCA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -568000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -196000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 5000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Net PPE: 32279000000.00
HCA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1176000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -14667000000.00
HCA income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 3849000000.00
HCA income_statement (quarterly, 2025-06-30) — Normalized Income: 1655277000.00
HCA cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 4210000000.00
HCA cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 3000000.00
HCA income_statement (quarterly, 2025-06-30) — Operating Income: 2967000000.00
HCA income_statement (quarterly, 2025-06-30) — Operating Revenue: 18079000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 236143900.00
HCA balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2373000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -309000000.00
HCA income_statement (quarterly, 2025-06-30) — Other Income Expense: 16000000.00
HCA cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 62000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 236000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 3575000000.00
HCA income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 3793000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Other Properties: 66544000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Payables: 4250000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 10835000000.00
HCA income_statement (quarterly, 2025-06-30) — Pretax Income: 2415000000.00
HCA cash_flow (quarterly, 2025-06-30) — Purchase Of Business: -99000000.00
HCA cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1176000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Receivables: 10459000000.00
HCA income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 10982000000.00
HCA income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 863000000.00
HCA cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1765000000.00
HCA cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -2505000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -4087000000.00
HCA cash_flow (quarterly, 2025-06-30) — Sale Of Business: 6000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Share Issued: 236143900.00
HCA income_statement (quarterly, 2025-06-30) — Special Income Charges: -3000000.00
HCA cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 99000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -4394000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -14667000000.00
HCA income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -723000.00
HCA income_statement (quarterly, 2025-06-30) — Tax Provision: 524000000.00
HCA income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
HCA balance_sheet (quarterly, 2025-06-30) — Total Assets: 59536000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 34985000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Total Debt: 46364000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -1238000000.00
HCA income_statement (quarterly, 2025-06-30) — Total Expenses: 15638000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 60774000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 43973000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 44835000000.00
HCA income_statement (quarterly, 2025-06-30) — Total Unusual Items: -3000000.00
HCA income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -3000000.00
HCA balance_sheet (quarterly, 2025-06-30) — Working Capital: -376000000.00
HCA income_statement (quarterly, 2025-09-30) — +Operating Expense: 5050000000.00
HCA income_statement (quarterly, 2025-09-30) — +Total Revenue: 19161000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4552000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 10428000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -34921000000.00
HCA income_statement (quarterly, 2025-09-30) — Basic Average Shares: 229845100.00
HCA income_statement (quarterly, 2025-09-30) — Basic EPS: 7.15
HCA cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 939000000.00
HCA cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1288000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1838000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 997000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 997000000.00
HCA cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -166000000.00
HCA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -2967000000.00
HCA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1388000000.00
HCA cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 4416000000.00
HCA cash_flow (quarterly, 2025-09-30) — Change In Inventory: 302000000.00
HCA cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 705000000.00
HCA cash_flow (quarterly, 2025-09-30) — Change In Receivables: 25000000.00
HCA cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1032000000.00
HCA cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 25000000.00
HCA cash_flow (quarterly, 2025-09-30) — Changes In Cash: 61000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000000.00
HCA cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -166000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -5335000000.00
HCA cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2498000000.00
HCA income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 11146000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 7234000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Current Assets: 15285000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Current Debt: 6110000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 6110000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 17896000000.00
HCA cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 434000000.00
HCA cash_flow (quarterly, 2025-09-30) — Deferred Tax: 434000000.00
HCA cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 889000000.00
HCA income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 889000000.00
HCA cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 889000000.00
HCA income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 889000000.00
HCA income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 236181000.00
HCA income_statement (quarterly, 2025-09-30) — Diluted EPS: 6.96
HCA income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1643000000.00
HCA income_statement (quarterly, 2025-09-30) — EBIT: 2979000000.00
HCA income_statement (quarterly, 2025-09-30) — EBITDA: 3868000000.00
HCA income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 16000000.00
HCA cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -3000000.00
HCA cash_flow (quarterly, 2025-09-30) — End Cash Position: 997000000.00
HCA cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -2967000000.00
HCA cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 3128000000.00
HCA cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 2000000.00
HCA income_statement (quarterly, 2025-09-30) — Gain On Sale Of Business: -2000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -317000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 10275000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Gross PPE: 67604000000.00
HCA income_statement (quarterly, 2025-09-30) — Gross Profit: 8015000000.00
HCA cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 81000000.00
HCA income_statement (quarterly, 2025-09-30) — Interest Expense: 561000000.00
HCA income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 561000000.00
HCA cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 622000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Inventory: 1734000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Invested Capital: 39176000000.00
HCA cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1388000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 1227000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Investments In Other Ventures Under Equity Method: 654000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Investmentsin Subsidiariesat Cost: 573000000.00
HCA cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 1906000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1838000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 38401000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 40239000000.00
HCA cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 1906000000.00
HCA cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -174000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 1227000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Minority Interest: 3176000000.00
HCA income_statement (quarterly, 2025-09-30) — Minority Interests: -260000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -25000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2498000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Net Debt: 43514000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Income: 1643000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1643000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 1903000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 1643000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 1643000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 1903000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1903000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Interest Income: -561000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -67000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -36000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 1732000000.00
HCA income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -561000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -267000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -8000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Net PPE: 32683000000.00
HCA cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1288000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -15610000000.00
HCA income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 3870000000.00
HCA income_statement (quarterly, 2025-09-30) — Normalized Income: 1644522000.00
HCA cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 4416000000.00
HCA cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2000000.00
HCA income_statement (quarterly, 2025-09-30) — Operating Income: 2965000000.00
HCA income_statement (quarterly, 2025-09-30) — Operating Revenue: 18517000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 229845100.00
HCA balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2126000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -317000000.00
HCA income_statement (quarterly, 2025-09-30) — Other Income Expense: 14000000.00
HCA cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 52000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 277000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 3771000000.00
HCA income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 4161000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Other Properties: 67604000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Payables: 4552000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 11786000000.00
HCA income_statement (quarterly, 2025-09-30) — Pretax Income: 2418000000.00
HCA cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -35000000.00
HCA cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1288000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Receivables: 10428000000.00
HCA income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 11146000000.00
HCA income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 889000000.00
HCA cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -174000000.00
HCA cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2498000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -5020000000.00
HCA cash_flow (quarterly, 2025-09-30) — Sale Of Business: 10000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Share Issued: 229845100.00
HCA income_statement (quarterly, 2025-09-30) — Special Income Charges: -2000000.00
HCA cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 104000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -5335000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -15610000000.00
HCA income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -478000.00
HCA income_statement (quarterly, 2025-09-30) — Tax Provision: 515000000.00
HCA income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
HCA balance_sheet (quarterly, 2025-09-30) — Total Assets: 59747000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 33066000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Total Debt: 46349000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -2159000000.00
HCA income_statement (quarterly, 2025-09-30) — Total Expenses: 16196000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 61906000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 44462000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 44010000000.00
HCA income_statement (quarterly, 2025-09-30) — Total Unusual Items: -2000000.00
HCA income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -2000000.00
HCA balance_sheet (quarterly, 2025-09-30) — Working Capital: -2611000000.00
HCA income_statement (annual, 2025-12-31) — +Operating Expense: 19409000000.00
HCA income_statement (quarterly, 2025-12-31) — +Operating Expense: 4998000000.00
HCA income_statement (annual, 2025-12-31) — +Total Revenue: 75600000000.00
HCA income_statement (quarterly, 2025-12-31) — +Total Revenue: 19513000000.00
HCA balance_sheet (annual, 2025-12-31) — Accounts Payable: 4659000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 4659000000.00
HCA balance_sheet (annual, 2025-12-31) — Accounts Receivable: 10867000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 10867000000.00
HCA balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -35134000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -35134000000.00
HCA income_statement (annual, 2025-12-31) — Basic Average Shares: 224605100.00
HCA income_statement (quarterly, 2025-12-31) — Basic Average Shares: 224605100.00
HCA income_statement (annual, 2025-12-31) — Basic EPS: 30.20
HCA income_statement (quarterly, 2025-12-31) — Basic EPS: 8.36
HCA cash_flow (annual, 2025-12-31) — Beginning Cash Position: 1933000000.00
HCA cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 997000000.00
HCA balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 23726000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 23726000000.00
HCA cash_flow (annual, 2025-12-31) — Capital Expenditure: -4944000000.00
HCA cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1489000000.00
HCA balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2205000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2205000000.00
HCA balance_sheet (annual, 2025-12-31) — Capital Stock: 2000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000000.00
HCA balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 1040000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 1040000000.00
HCA balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1040000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1040000000.00
HCA cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -679000000.00
HCA cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -162000000.00
HCA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8550000000.00
HCA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -999000000.00
HCA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4988000000.00
HCA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1317000000.00
HCA cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 12636000000.00
HCA cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2359000000.00
HCA cash_flow (annual, 2025-12-31) — Change In Inventory: -154000000.00
HCA cash_flow (quarterly, 2025-12-31) — Change In Inventory: -29000000.00
HCA cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 666000000.00
HCA cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 637000000.00
HCA cash_flow (annual, 2025-12-31) — Change In Receivables: -94000000.00
HCA cash_flow (quarterly, 2025-12-31) — Change In Receivables: -439000000.00
HCA cash_flow (annual, 2025-12-31) — Change In Working Capital: 418000000.00
HCA cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 169000000.00
HCA cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -94000000.00
HCA cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -439000000.00
HCA cash_flow (annual, 2025-12-31) — Changes In Cash: -902000000.00
HCA cash_flow (quarterly, 2025-12-31) — Changes In Cash: 43000000.00
HCA balance_sheet (annual, 2025-12-31) — Common Stock: 2000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000000.00
HCA cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -679000000.00
HCA cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -162000000.00
HCA balance_sheet (annual, 2025-12-31) — Common Stock Equity: -6027000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -6027000000.00
HCA cash_flow (annual, 2025-12-31) — Common Stock Payments: -10067000000.00
HCA cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -2558000000.00
HCA balance_sheet (annual, 2025-12-31) — Construction In Progress: 2145000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 2145000000.00
HCA income_statement (annual, 2025-12-31) — Cost Of Revenue: 44226000000.00
HCA income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11337000000.00
HCA balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4967000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 4967000000.00
HCA balance_sheet (annual, 2025-12-31) — Current Assets: 15783000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Current Assets: 15783000000.00
HCA balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 352000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 352000000.00
HCA balance_sheet (annual, 2025-12-31) — Current Debt: 4889000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Current Debt: 4889000000.00
HCA balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5241000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5241000000.00
HCA balance_sheet (annual, 2025-12-31) — Current Liabilities: 16350000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 16350000000.00
HCA cash_flow (annual, 2025-12-31) — Deferred Income Tax: 310000000.00
HCA cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -1004000000.00
HCA cash_flow (annual, 2025-12-31) — Deferred Tax: 310000000.00
HCA cash_flow (quarterly, 2025-12-31) — Deferred Tax: -1004000000.00
HCA cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3523000000.00
HCA cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 911000000.00
HCA income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 3523000000.00
HCA income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 911000000.00
HCA cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3523000000.00
HCA cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 911000000.00
HCA income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 3523000000.00
HCA income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 911000000.00
HCA income_statement (annual, 2025-12-31) — Diluted Average Shares: 239495000.00
HCA income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 230710000.00
HCA income_statement (annual, 2025-12-31) — Diluted EPS: 28.33
HCA income_statement (quarterly, 2025-12-31) — Diluted EPS: 8.14
HCA income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 6784000000.00
HCA income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 1878000000.00
HCA income_statement (annual, 2025-12-31) — EBIT: 12080000000.00
HCA income_statement (quarterly, 2025-12-31) — EBIT: 3244000000.00
HCA income_statement (annual, 2025-12-31) — EBITDA: 15603000000.00
HCA income_statement (quarterly, 2025-12-31) — EBITDA: 4155000000.00
HCA income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 78000000.00
HCA income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 25000000.00
HCA cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 9000000.00
HCA cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
HCA cash_flow (annual, 2025-12-31) — End Cash Position: 1040000000.00
HCA cash_flow (quarterly, 2025-12-31) — End Cash Position: 1040000000.00
HCA cash_flow (annual, 2025-12-31) — Financing Cash Flow: -8550000000.00
HCA cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -999000000.00
HCA cash_flow (annual, 2025-12-31) — Free Cash Flow: 7692000000.00
HCA cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 870000000.00
HCA cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -37000000.00
HCA cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -41000000.00
HCA income_statement (annual, 2025-12-31) — Gain On Sale Of Business: 37000000.00
HCA income_statement (quarterly, 2025-12-31) — Gain On Sale Of Business: 41000000.00
HCA balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -305000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -305000000.00
HCA balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 10293000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 10293000000.00
HCA balance_sheet (annual, 2025-12-31) — Gross PPE: 68405000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Gross PPE: 68405000000.00
HCA income_statement (annual, 2025-12-31) — Gross Profit: 31374000000.00
HCA income_statement (quarterly, 2025-12-31) — Gross Profit: 8176000000.00
HCA cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1740000000.00
HCA cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1513000000.00
HCA income_statement (annual, 2025-12-31) — Interest Expense: 2248000000.00
HCA income_statement (quarterly, 2025-12-31) — Interest Expense: 572000000.00
HCA income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2248000000.00
HCA income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 572000000.00
HCA cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 2207000000.00
HCA cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 511000000.00
HCA balance_sheet (annual, 2025-12-31) — Interest Payable: 499000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Interest Payable: 499000000.00
HCA balance_sheet (annual, 2025-12-31) — Inventory: 1652000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Inventory: 1652000000.00
HCA balance_sheet (annual, 2025-12-31) — Invested Capital: 40465000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Invested Capital: 40465000000.00
HCA cash_flow (annual, 2025-12-31) — Investing Cash Flow: -4988000000.00
HCA cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1317000000.00
HCA balance_sheet (annual, 2025-12-31) — Investments And Advances: 1118000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1118000000.00
HCA balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 633000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 633000000.00
HCA balance_sheet (annual, 2025-12-31) — Investmentsin Subsidiariesat Cost: 485000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Investmentsin Subsidiariesat Cost: 485000000.00
HCA cash_flow (annual, 2025-12-31) — Issuance Of Debt: 8474000000.00
HCA cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 1335000000.00
HCA balance_sheet (annual, 2025-12-31) — Land And Improvements: 3415000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 3415000000.00
HCA balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1853000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1853000000.00
HCA balance_sheet (annual, 2025-12-31) — Long Term Debt: 41603000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 41603000000.00
HCA balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 43456000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 43456000000.00
HCA cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 8474000000.00
HCA cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 1335000000.00
HCA cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -7389000000.00
HCA cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1555000000.00
HCA balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1118000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1118000000.00
HCA balance_sheet (annual, 2025-12-31) — Minority Interest: 3256000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Minority Interest: 3256000000.00
HCA income_statement (annual, 2025-12-31) — Minority Interests: -998000000.00
HCA income_statement (quarterly, 2025-12-31) — Minority Interests: -285000000.00
HCA cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -128000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 56000000.00
HCA cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -10067000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -2558000000.00
HCA balance_sheet (annual, 2025-12-31) — Net Debt: 45452000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Net Debt: 45452000000.00
HCA income_statement (annual, 2025-12-31) — Net Income: 6784000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Income: 1878000000.00
HCA income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 6784000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 1878000000.00
HCA income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 7782000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2163000000.00
HCA income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 6784000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 1878000000.00
HCA income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 6784000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 1878000000.00
HCA cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 7782000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2163000000.00
HCA income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 7782000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2163000000.00
HCA income_statement (annual, 2025-12-31) — Net Interest Income: -2248000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Interest Income: -572000000.00
HCA cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 72000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 98000000.00
HCA cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 3287000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1982000000.00
HCA cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1085000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -220000000.00
HCA income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2248000000.00
HCA income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -572000000.00
HCA cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -1091000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -261000000.00
HCA cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 12000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 18000000.00
HCA balance_sheet (annual, 2025-12-31) — Net PPE: 33271000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Net PPE: 33271000000.00
HCA cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4944000000.00
HCA cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1489000000.00
HCA cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 2202000000.00
HCA balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -16320000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -16320000000.00
HCA income_statement (annual, 2025-12-31) — Normalized EBITDA: 15566000000.00
HCA income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 4114000000.00
HCA income_statement (annual, 2025-12-31) — Normalized Income: 6754733000.00
HCA income_statement (quarterly, 2025-12-31) — Normalized Income: 1844810254.49
HCA cash_flow (annual, 2025-12-31) — Operating Cash Flow: 12636000000.00
HCA cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 2359000000.00
HCA cash_flow (annual, 2025-12-31) — Operating Gains Losses: -37000000.00
HCA cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -41000000.00
HCA income_statement (annual, 2025-12-31) — Operating Income: 11965000000.00
HCA income_statement (quarterly, 2025-12-31) — Operating Income: 3178000000.00
HCA income_statement (annual, 2025-12-31) — Operating Revenue: 73142000000.00
HCA income_statement (quarterly, 2025-12-31) — Operating Revenue: 18797000000.00
HCA balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 224605100.00
HCA balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 224605100.00
HCA balance_sheet (annual, 2025-12-31) — Other Current Assets: 2224000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2224000000.00
HCA balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 4889000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 4889000000.00
HCA balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -305000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -305000000.00
HCA income_statement (annual, 2025-12-31) — Other Income Expense: 115000000.00
HCA income_statement (quarterly, 2025-12-31) — Other Income Expense: 66000000.00
HCA cash_flow (annual, 2025-12-31) — Other Non Cash Items: 239000000.00
HCA cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 61000000.00
HCA balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 255000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 255000000.00
HCA balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 3685000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 3685000000.00
HCA income_statement (annual, 2025-12-31) — Other Operating Expenses: 15886000000.00
HCA income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 4087000000.00
HCA balance_sheet (annual, 2025-12-31) — Other Properties: 39119000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Other Properties: 39119000000.00
HCA balance_sheet (annual, 2025-12-31) — Payables: 5163000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Payables: 5163000000.00
HCA balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 10130000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 10130000000.00
HCA balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 979000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 979000000.00
HCA income_statement (annual, 2025-12-31) — Pretax Income: 9832000000.00
HCA income_statement (quarterly, 2025-12-31) — Pretax Income: 2672000000.00
HCA balance_sheet (annual, 2025-12-31) — Properties: 0.00
HCA balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HCA cash_flow (annual, 2025-12-31) — Purchase Of Business: -397000000.00
HCA cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -36000000.00
HCA cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4944000000.00
HCA cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1489000000.00
HCA balance_sheet (annual, 2025-12-31) — Receivables: 10867000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Receivables: 10867000000.00
HCA income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 44226000000.00
HCA income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11337000000.00
HCA income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3523000000.00
HCA income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 911000000.00
HCA cash_flow (annual, 2025-12-31) — Repayment Of Debt: -7389000000.00
HCA cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1555000000.00
HCA cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -10067000000.00
HCA cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2558000000.00
HCA balance_sheet (annual, 2025-12-31) — Retained Earnings: -5724000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -5724000000.00
HCA cash_flow (annual, 2025-12-31) — Sale Of Business: 269000000.00
HCA cash_flow (quarterly, 2025-12-31) — Sale Of Business: 92000000.00
HCA balance_sheet (annual, 2025-12-31) — Share Issued: 224605100.00
HCA balance_sheet (quarterly, 2025-12-31) — Share Issued: 224605100.00
HCA income_statement (annual, 2025-12-31) — Special Income Charges: 37000000.00
HCA income_statement (quarterly, 2025-12-31) — Special Income Charges: 41000000.00
HCA cash_flow (annual, 2025-12-31) — Stock Based Compensation: 401000000.00
HCA cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 100000000.00
HCA balance_sheet (annual, 2025-12-31) — Stockholders Equity: -6027000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -6027000000.00
HCA balance_sheet (annual, 2025-12-31) — Tangible Book Value: -16320000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -16320000000.00
HCA income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 7733000.00
HCA income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 7810254.49
HCA income_statement (annual, 2025-12-31) — Tax Provision: 2050000000.00
HCA income_statement (quarterly, 2025-12-31) — Tax Provision: 509000000.00
HCA income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
HCA income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.19
HCA balance_sheet (annual, 2025-12-31) — Total Assets: 60720000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Assets: 60720000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Capitalization: 35576000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 35576000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Debt: 48697000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Debt: 48697000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -2771000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -2771000000.00
HCA income_statement (annual, 2025-12-31) — Total Expenses: 63635000000.00
HCA income_statement (quarterly, 2025-12-31) — Total Expenses: 16335000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 63491000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 63491000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 44937000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 44937000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 47141000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 47141000000.00
HCA balance_sheet (annual, 2025-12-31) — Total Tax Payable: 504000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 504000000.00
HCA income_statement (annual, 2025-12-31) — Total Unusual Items: 37000000.00
HCA income_statement (quarterly, 2025-12-31) — Total Unusual Items: 41000000.00
HCA income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 37000000.00
HCA income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 41000000.00
HCA balance_sheet (annual, 2025-12-31) — Working Capital: -567000000.00
HCA balance_sheet (quarterly, 2025-12-31) — Working Capital: -567000000.00
HCA income_statement (quarterly, 2026-03-31) — +Operating Expense: 5110000000.00
HCA income_statement (quarterly, 2026-03-31) — +Total Revenue: 19109000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 4806000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 11324000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -35893000000.00
HCA income_statement (quarterly, 2026-03-31) — Basic Average Shares: 222530900.00
HCA income_statement (quarterly, 2026-03-31) — Basic EPS: 7.28
HCA cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1040000000.00
HCA cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1119000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1822000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 940000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 940000000.00
HCA cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -183000000.00
HCA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -830000000.00
HCA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1282000000.00
HCA cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2014000000.00
HCA cash_flow (quarterly, 2026-03-31) — Change In Inventory: 80000000.00
HCA cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -990000000.00
HCA cash_flow (quarterly, 2026-03-31) — Change In Receivables: -463000000.00
HCA cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1373000000.00
HCA cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -463000000.00
HCA cash_flow (quarterly, 2026-03-31) — Changes In Cash: -98000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000000.00
HCA cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -183000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -6303000000.00
HCA cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1571000000.00
HCA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11136000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 5920000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Current Assets: 16052000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Current Debt: 8532000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 8532000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 19258000000.00
HCA cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 435000000.00
HCA cash_flow (quarterly, 2026-03-31) — Deferred Tax: 435000000.00
HCA cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 930000000.00
HCA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 930000000.00
HCA cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 930000000.00